S&P 500   3,964.57 (-0.33%)
DOW   32,461.38 (+0.09%)
QQQ   305.26 (-1.13%)
AAPL   156.38 (-1.20%)
MSFT   272.61 (-1.36%)
META   198.95 (-1.92%)
GOOGL   100.22 (-2.19%)
AMZN   97.26 (-0.80%)
TSLA   187.80 (-2.09%)
NVDA   259.43 (-2.22%)
NIO   9.04 (+1.23%)
BABA   92.88 (+7.85%)
AMD   93.35 (-3.37%)
T   18.85 (-0.11%)
F   11.51 (-0.09%)
MU   57.84 (-3.26%)
CGC   1.86 (-1.33%)
GE   93.14 (-0.18%)
DIS   95.10 (-0.54%)
AMC   4.57 (+0.44%)
PFE   40.03 (-0.47%)
PYPL   72.76 (-0.74%)
NFLX   328.98 (+0.40%)
S&P 500   3,964.57 (-0.33%)
DOW   32,461.38 (+0.09%)
QQQ   305.26 (-1.13%)
AAPL   156.38 (-1.20%)
MSFT   272.61 (-1.36%)
META   198.95 (-1.92%)
GOOGL   100.22 (-2.19%)
AMZN   97.26 (-0.80%)
TSLA   187.80 (-2.09%)
NVDA   259.43 (-2.22%)
NIO   9.04 (+1.23%)
BABA   92.88 (+7.85%)
AMD   93.35 (-3.37%)
T   18.85 (-0.11%)
F   11.51 (-0.09%)
MU   57.84 (-3.26%)
CGC   1.86 (-1.33%)
GE   93.14 (-0.18%)
DIS   95.10 (-0.54%)
AMC   4.57 (+0.44%)
PFE   40.03 (-0.47%)
PYPL   72.76 (-0.74%)
NFLX   328.98 (+0.40%)
S&P 500   3,964.57 (-0.33%)
DOW   32,461.38 (+0.09%)
QQQ   305.26 (-1.13%)
AAPL   156.38 (-1.20%)
MSFT   272.61 (-1.36%)
META   198.95 (-1.92%)
GOOGL   100.22 (-2.19%)
AMZN   97.26 (-0.80%)
TSLA   187.80 (-2.09%)
NVDA   259.43 (-2.22%)
NIO   9.04 (+1.23%)
BABA   92.88 (+7.85%)
AMD   93.35 (-3.37%)
T   18.85 (-0.11%)
F   11.51 (-0.09%)
MU   57.84 (-3.26%)
CGC   1.86 (-1.33%)
GE   93.14 (-0.18%)
DIS   95.10 (-0.54%)
AMC   4.57 (+0.44%)
PFE   40.03 (-0.47%)
PYPL   72.76 (-0.74%)
NFLX   328.98 (+0.40%)
S&P 500   3,964.57 (-0.33%)
DOW   32,461.38 (+0.09%)
QQQ   305.26 (-1.13%)
AAPL   156.38 (-1.20%)
MSFT   272.61 (-1.36%)
META   198.95 (-1.92%)
GOOGL   100.22 (-2.19%)
AMZN   97.26 (-0.80%)
TSLA   187.80 (-2.09%)
NVDA   259.43 (-2.22%)
NIO   9.04 (+1.23%)
BABA   92.88 (+7.85%)
AMD   93.35 (-3.37%)
T   18.85 (-0.11%)
F   11.51 (-0.09%)
MU   57.84 (-3.26%)
CGC   1.86 (-1.33%)
GE   93.14 (-0.18%)
DIS   95.10 (-0.54%)
AMC   4.57 (+0.44%)
PFE   40.03 (-0.47%)
PYPL   72.76 (-0.74%)
NFLX   328.98 (+0.40%)
NASDAQ:ARDS

Aridis Pharmaceuticals - ARDS Institutional Ownership

$0.38
-0.01 (-2.51%)
(As of 03/28/2023 10:11 AM ET)
Add
Compare
Today's Range
$0.38
▼
$0.39
50-Day Range
$0.36
▼
$1.30
52-Week Range
$0.35
▼
$2.77
Volume
25,711 shs
Average Volume
1.67 million shs
Market Capitalization
$11.44 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.00

Institutional Ownership Changes (13F Filings) for Aridis Pharmaceuticals (NASDAQ:ARDS)

Current
Institutional Ownership
Percentage
10.89%
Number of
Institutional Buyers
(last 12 months)
7
Total
Institutional Inflows
(last 12 months)
$3.65 M
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$11,000.00
Skip Chart & View Institutional Buying and Selling Data

ARDS Institutional Buying and Selling by Quarter

Get ARDS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Aridis Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Aridis Pharmaceuticals Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/15/2023Armistice Capital LLC2,068,000$2.44M0.0%N/A9.938%
12/2/2022EP Wealth Advisors LLC50,000$47K0.0%N/A0.240%
11/15/2022State Street Corp43,247$40K0.0%+54.2%0.244%
7/19/2022Commonwealth Equity Services LLC567,200$0.62M0.0%-1.7%3.205%
5/13/2022Vanguard Group Inc.524,122$0.92M0.0%+3.3%2.961%
5/12/2022Group One Trading L.P.27,066$48K0.0%N/A0.153%
5/4/2022Commonwealth Equity Services LLC577,200$1.02M0.0%+2,757.4%3.261%
4/14/2022Minot Wealth Management LLC50,000$88K0.0%N/A0.356%
1/31/2022Commonwealth Equity Services LLC20,200$47K0.0%N/A0.144%
11/12/2021AIGH Capital Management LLC150,591$0.55M0.1%-67.2%1.243%
11/9/2021BlackRock Inc.42,227$0.16M0.0%+33.6%0.348%
11/9/2021Wealth Architects LLC14,077$52K0.0%N/A0.116%
8/13/2021Vanguard Group Inc.159,946$1.18M0.0%+6.9%1.424%
8/12/2021AIGH Capital Management LLC459,261$3.33M0.6%+8.5%4.088%
7/19/2021Minot Wealth Management LLC25,000$0.15M0.0%-65.4%0.223%
5/19/2021Worth Venture Partners LLC105,413$0.62M0.3%+19.9%0.938%
5/18/2021Perritt Capital Management Inc.10,100$60K0.0%N/A0.090%
5/7/2021BlackRock Inc.26,381$0.16M0.0%+11.4%0.296%
4/29/2021Minot Wealth Management LLC72,230$0.43M0.1%-45.4%0.643%
2/17/2021Worth Venture Partners LLC87,932$0.53M0.4%N/A0.874%
1/28/2021Minot Wealth Management LLC132,283$0.80M0.2%N/A1.314%
11/6/2020BlackRock Inc.22,600$0.16M0.0%+15.1%0.253%
11/27/2019Millennium Management LLC25,569$0.17M0.0%N/A0.287%
8/14/2019Vanguard Group Inc.43,281$0.44M0.0%-5.2%0.534%
2/15/2019Millennium Management LLC12,112$0.13M0.0%-48.6%0.149%
(Data available from 1/1/2016 forward)













ARDS Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ARDS shares?

During the previous two years, 12 institutional investors and hedge funds held shares of Aridis Pharmaceuticals. The most heavily invested institutionals were Armistice Capital LLC ($2.44M), Vanguard Group Inc. ($0.92M), Commonwealth Equity Services LLC ($0.62M), Worth Venture Partners LLC ($0.62M), AIGH Capital Management LLC ($0.55M), BlackRock Inc. ($0.16M), and Minot Wealth Management LLC ($88K).Learn more on ARDS's institutional investors.

What percentage of Aridis Pharmaceuticals stock is owned by institutional investors?

10.89% of Aridis Pharmaceuticals stock is owned by institutional investors. Learn more on ARDS's institutional investor holdings.

Which institutional investors have been buying Aridis Pharmaceuticals stock?

Of the 12 institutional investors that purchased Aridis Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Armistice Capital LLC ($2.07M), Commonwealth Equity Services LLC ($0.58M), EP Wealth Advisors LLC ($50K), Minot Wealth Management LLC ($50K), AIGH Capital Management LLC ($35.90K), Vanguard Group Inc. ($27.07K), and Group One Trading L.P. ($27.07K).

How much institutional buying is happening at Aridis Pharmaceuticals?

Institutional investors have bought a total of 2,905,417 shares in the last 24 months. This purchase volume represents approximately $4.30M in transactions.

Which Aridis Pharmaceuticals major shareholders have been selling company stock?

The following institutional investors have sold Aridis Pharmaceuticals stock in the last 24 months: AIGH Capital Management LLC ($0.31M), Minot Wealth Management LLC ($0.11M), and Commonwealth Equity Services LLC ($10K).

How much institutional selling is happening at Aridis Pharmaceuticals?

Institutional investors have sold a total of 425,953 shares in the last 24 months. This volume of shares sold represents approximately $1.85M in transactions.

This page (NASDAQ:ARDS) was last updated on 3/28/2023 by MarketBeat.com Staff